Lymphoma is generally categorized into Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. Some patients with Hodgkin’s lymphoma may be cured, while patients with non-Hodgkin’s lymphoma are prone to relapse even if their condition improves, which is not easy to be cured. 1. The treatment of Hodgkin’s lymphoma in general mostly adopts the comprehensive treatment method of chemotherapy combined with radiotherapy, and the treatment response is usually better. Generally speaking, the 5-year survival rate of early-stage Hodgkin’s lymphoma can reach more than 90% after treatment, which means most of the patients can be cured. Drugs include dacarbazine, bleomycin, vincristine, adriamycin and so on. 2. Non-Hodgkin’s lymphoma is a heterogeneous group of lymphomas, and the survival rate varies greatly according to the patient’s physical condition and the type of pathology. For example, inert lymphomas such as follicular lymphoma can have a 6-year survival rate of 60%, while aggressive lymphomas such as diffuse large B-cell lymphoma can only have a 6-year survival rate of about 40%, and lymphoblastoid lymphoma has a 4-year survival rate of only 30%. Therapeutic drugs include vincristine and cyclophosphamide. It is recommended that lymphoma patients, under the guidance of a physician to treat as early as possible, so as not to delay the condition and increase the difficulty of treatment.